Brian A Boyle

Summary

Publications

  1. ncbi request reprint Efficacy and safety of once-daily antiretroviral therapy
    Brian A Boyle
    Department of International Medicine and Infectious Disease, New York Presbyterian Hospital Weill Medical College of Cornell University, New York, USA
    AIDS Read 12:90-2, 95-6, 109. 2002
  2. ncbi request reprint Considerations in selecting protease inhibitor therapy
    Brian A Boyle
    Weill Medical College of Cornell University, New York, NY 10021, USA
    AIDS Rev 6:218-25. 2004
  3. doi request reprint Randomization to once-daily stavudine extended release/lamivudine/efavirenz versus a more frequent regimen improves adherence while maintaining viral suppression
    Brian A Boyle
    Weill Medical College of Cornell University, New York, New York, USA
    HIV Clin Trials 9:164-76. 2008
  4. ncbi request reprint Advances in HIV therapeutics: the 14th CROI
    Brian A Boyle
    Department of International Medicine and Infectious Diseases, New York Presbyterian Hospital Weill Medical College of Cornell University, New York, USA
    AIDS Read 17:268-70, 272-4, 283-6. 2007
  5. ncbi request reprint XVI International AIDS Conference: Part 2
    Brian A Boyle
    Department of International Medicine and Infectious Diseases, New York Presbyterian Hospital Weill Medical College of Cornell University, New York, USA
    AIDS Read 16:581-4, 591-2. 2006
  6. ncbi request reprint The continuing evolution of HIV therapy
    Brian A Boyle
    Department of International Medicine and Infectious Disease, New York Presbyterian Hospital Weill Medical College, New York, USA
    AIDS Read 13:576-8, 582. 2003
  7. ncbi request reprint Update on antiretroviral therapy: the 15th CROI
    Brian A Boyle
    Department of International Medicine and Infectious Diseases, New York Presbyterian Hospital Weill Medical College of Cornell University, New York, USA
    AIDS Read 18:273-8, C3. 2008
  8. ncbi request reprint XVI International AIDS Conference: Part 1
    Brian A Boyle
    Department of International Medicine and Infectious Diseases, New York Presbyterian Hospital Weill Medical College of Cornell University, New York, USA
    AIDS Read 16:517-21. 2006
  9. ncbi request reprint Antiretroviral update: further validation of the guidelines
    Brian A Boyle
    Department of International Medicine and Infectious Disease, New York Presbyterian Hospital Weill Medical College, Cornell University, New York, USA
    AIDS Read 16:83-6. 2006
  10. ncbi request reprint Recent developments in HIV therapeutics
    Brian A Boyle
    Department of International Medicine and Infectious Diseases, New York Presbyterian Hospital Weill Medical College of Cornell University, New York, USA
    AIDS Read 17:162-6, C3. 2007

Detail Information

Publications36

  1. ncbi request reprint Efficacy and safety of once-daily antiretroviral therapy
    Brian A Boyle
    Department of International Medicine and Infectious Disease, New York Presbyterian Hospital Weill Medical College of Cornell University, New York, USA
    AIDS Read 12:90-2, 95-6, 109. 2002
  2. ncbi request reprint Considerations in selecting protease inhibitor therapy
    Brian A Boyle
    Weill Medical College of Cornell University, New York, NY 10021, USA
    AIDS Rev 6:218-25. 2004
    ..Protease inhibitor characteristics and patient preferences should be considered in selecting the protease inhibitor that maximizes the opportunity for long-term efficacy and tolerability of highly active antiretroviral therapy...
  3. doi request reprint Randomization to once-daily stavudine extended release/lamivudine/efavirenz versus a more frequent regimen improves adherence while maintaining viral suppression
    Brian A Boyle
    Weill Medical College of Cornell University, New York, New York, USA
    HIV Clin Trials 9:164-76. 2008
    ..In antiretroviral (ARV) therapy, pill burden, dosing frequency, and regimen complexity adversely affect adherence. We sought to evaluate the effect of regimen simplification on maintenance of virologic suppression and treatment adherence...
  4. ncbi request reprint Advances in HIV therapeutics: the 14th CROI
    Brian A Boyle
    Department of International Medicine and Infectious Diseases, New York Presbyterian Hospital Weill Medical College of Cornell University, New York, USA
    AIDS Read 17:268-70, 272-4, 283-6. 2007
  5. ncbi request reprint XVI International AIDS Conference: Part 2
    Brian A Boyle
    Department of International Medicine and Infectious Diseases, New York Presbyterian Hospital Weill Medical College of Cornell University, New York, USA
    AIDS Read 16:581-4, 591-2. 2006
  6. ncbi request reprint The continuing evolution of HIV therapy
    Brian A Boyle
    Department of International Medicine and Infectious Disease, New York Presbyterian Hospital Weill Medical College, New York, USA
    AIDS Read 13:576-8, 582. 2003
  7. ncbi request reprint Update on antiretroviral therapy: the 15th CROI
    Brian A Boyle
    Department of International Medicine and Infectious Diseases, New York Presbyterian Hospital Weill Medical College of Cornell University, New York, USA
    AIDS Read 18:273-8, C3. 2008
  8. ncbi request reprint XVI International AIDS Conference: Part 1
    Brian A Boyle
    Department of International Medicine and Infectious Diseases, New York Presbyterian Hospital Weill Medical College of Cornell University, New York, USA
    AIDS Read 16:517-21. 2006
  9. ncbi request reprint Antiretroviral update: further validation of the guidelines
    Brian A Boyle
    Department of International Medicine and Infectious Disease, New York Presbyterian Hospital Weill Medical College, Cornell University, New York, USA
    AIDS Read 16:83-6. 2006
  10. ncbi request reprint Recent developments in HIV therapeutics
    Brian A Boyle
    Department of International Medicine and Infectious Diseases, New York Presbyterian Hospital Weill Medical College of Cornell University, New York, USA
    AIDS Read 17:162-6, C3. 2007
  11. ncbi request reprint Recent developments in HIV treatment, Part 2
    Brian A Boyle
    Department of International Medicine and Infectious Disease, New York Presbyterian Hospital Weill Medical College of Cornell University, New York, USA
    AIDS Read 15:277-9, 284. 2005
  12. ncbi request reprint Tribulations and trials in HIV disease, Part 2
    Brian A Boyle
    Department of International Medicine and Infectious Diseases, New York Presbyterian Hospital Weill Medical College of Cornell University, New York, USA
    AIDS Read 16:291-4. 2006
  13. ncbi request reprint Recent developments in HIV research
    Brian A Boyle
    New York Presbyterian Hospital Weill Medical College, Cornell University, New York, USA
    AIDS Read 12:390-4, 407. 2002
  14. ncbi request reprint Improvements in protease inhibitor-based HAART
    Brian A Boyle
    Department of International Medicine and Infectious Disease Courtesy, New York Presbyterian Hospital Weill Medical College of Cornell University, New York, USA
    AIDS Read 15:659-60, 662. 2005
  15. ncbi request reprint Antiretroviral simplification: multiple benefits, some concerns
    Brian A Boyle
    Department of International Medicine and Infectious Disease, New York Presbyterian Hospital Weill Medical College of Cornell University, New York, USA
    AIDS Read 14:166, 169-70. 2004
  16. ncbi request reprint Antiretroviral choices under the DHHS guidelines
    Brian A Boyle
    Department of International Medicine and Infectious Disease, New York Presbyterian Hospital Weill Medical College of Cornell University, New York, USA
    AIDS Read 14:71-4, 77. 2004
  17. ncbi request reprint Issues in antiretroviral toxicity
    Brian A Boyle
    Department of International Medicine and Infectious Disease, New York Presbyterian Hospital Weill Medical College, Cornell University, New York, USA
    AIDS Read 13:459, 463-4, 468-9, 479. 2003
  18. pmc Nevirapine-related adverse events in a patient receiving a fixed-drug combination pill
    Olusoji J Daniel
    Centre for Special Studies Nigeria, Olabissi Onabanjo University Teaching Hospital, Sagamu, Ogun State, Nigeria
    J Natl Med Assoc 97:1719-21. 2005
    ..We strongly recommend a warning label on the bottle advising patients on the lead-in period and the signs and symptoms of significant rash...
  19. ncbi request reprint Advances in HIV treatment: the 3rd International AIDS Society Conference
    Brian A Boyle
    Department of International Medicine and Infectious Disease, New York Presbyterian Hospital Weill Medical College, Cornell University, New York, USA
    AIDS Read 15:552-7. 2005
  20. ncbi request reprint Tribulations and trials in HIV disease, Part I
    Brian A Boyle
    Department of International Medicine and Infectious Disease, New York Presbyterian Hospital Weill Medical College of Cornell University, New York, USA
    AIDS Read 16:240-4. 2006
  21. ncbi request reprint Updates on developments in HIV therapeutics
    Brian A Boyle
    Department of International Medicine and Infectious Disease, New York Presbyterian Hospital Weill Medical College of Cornell University, New York, USA
    AIDS Read 15:23-7. 2005
  22. ncbi request reprint Resistance studies from the 10th Conference on Retroviruses and Opportunistic Infections
    Brian A Boyle
    Department of International Medicine and Infectious Disease, New York Presbyterian Hospital Weill Medical College, Cornell University, New York, USA
    AIDS Read 13:166-71. 2003
  23. ncbi request reprint Recent research in HIV infection: Part I
    Brian A Boyle
    New York Presbyterian Hospital Weill Medical College of Cornell University, New York, USA
    AIDS Read 12:477-8, 483-5. 2002
  24. ncbi request reprint Recent research in HIV infection, part 2
    Brian A Boyle
    New York Presbyterian Hospital Weill Medical College of Cornell University, New York, USA
    AIDS Read 12:524-6, 539. 2002
  25. ncbi request reprint Health Insurance Portability and Accountability Act of 1996: new national medical privacy standards
    Brian A Boyle
    Department of International Medicine and Infectious Disease, New York Presbyterian Hospital Weill Medical College of Cornell University, New York, NY, USA
    AIDS Read 13:261-2, 265-6. 2003
  26. ncbi request reprint Selected abstracts from the 9th Annual Retrovirus Conference
    Brian A Boyle
    New York Presbyterian Hospital Weill Medical College of Cornell University, New York, USA
    AIDS Read 12:182-7. 2002
  27. ncbi request reprint Musculoskeletal manifestations of HIV infection
    Ann Marie Plate
    Hospital for Joint Diseases New York University Medical Center, New York, USA
    AIDS Read 13:62, 69-70, 72, 76. 2003
  28. ncbi request reprint Developments in HIV therapeutics
    Brian A Boyle
    Department of International Medicine and Infectious Disease, New York Presbyterian Hospital Weill Medical College of Cornell University, New York, USA
    AIDS Read 14:412-6, 452. 2004
  29. ncbi request reprint Current management challenges in HIV: antiretroviral resistance
    Daniel R Kuritzkes
    Harvard Medical School and Brigham and Women s Hospital, Boston, Massachusetts, USA
    AIDS Read 13:133-5, 138-42. 2003
    ..However, there is a need for additional trials to better define the role resistance testing may play in developing management approaches to mitigate or minimize emergence of resistant HIV...
  30. ncbi request reprint Advances in HIV therapeutics: news from the 4th International AIDS Society Conference
    Brian A Boyle
    AIDS Read 17:484-90. 2007
  31. ncbi request reprint Antiretroviral therapy: the "when to start" debates
    Calvin J Cohen
    Clin Infect Dis 39:1705-8. 2004
  32. ncbi request reprint Editorial comment: once-daily antiretroviral therapy
    Brian A Boyle
    AIDS Read 12:494-5. 2002
  33. ncbi request reprint Recent developments in HIV treatment, Part 1
    Brian A Boyle
    Department of International Medicine and Infectious Disease, New York Presbyterian Hospital Weill Medical College of Cornell University, USA
    AIDS Read 15:236-9, 243-4. 2005
  34. ncbi request reprint Excess and access: the continuing controversy regarding HIV and health care in Africa
    Marie Charles
    International Center for Equal Healthcare Access, Princeton, NJ, USA
    AIDS Read 12:288-92. 2002
  35. ncbi request reprint The HIV pandemic: the power of acting early
    Marie Charles
    International Center for Equal Healthcare Access, Princeton, New Jersey, USA
    AIDS Read 14:295-8, 303-4, 336. 2004
  36. ncbi request reprint Editorial comment: impact of darunavir for salvage therapy
    Brian A Boyle
    AIDS Read 17:160-1. 2007